Indian scientists develop a technology for fluorometric detection of COVID-19
NEW DELHI — Indian scientists have developed a new technology platform for fluorometric detection of pathogens including the detection of SARS-CoV-2—that has caused the ongoing Covid-19 pandemic.
The Team of scientists also demonstrated the potential of the new technology for the detection of SARS-CoV-2.
“This technology platform can also be used to detect other DNA/RNA pathogens such as HIV, influenza, HCV, Zika, Ebola, bacteria, and other mutating/evolving pathogens,” said a senior officer of the Ministry of Science and Technology.
The scientists from Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR), along with scientists from IISc (India Institute of Science), demonstrated a non canonical nucleic acid-based G-quadruplex (GQ) topology targeted reliable conformational polymorphism (GQ-RCP) platform to diagnose Covid-19 clinical samples, the Ministry said.
This work has also been published recently in the prestigious journal ‘ACS Sensors’ and the team has also filed a patent for the novel technology. This molecular detection platform can be integrated into field-deployable isothermal amplification assays with more reliability and sequence specificity, the Ministry said.
Article continues after this advertisement“The platform lays greater emphasis on deciphering and systematic characterization of a unique set of interactions in nucleic acids to attain stable and reliable noncanonical DNA/RNA targets. The RCP-based target validation is a general and modular approach for the development of noncanonical nucleic acid-targeted diagnostic platforms for diverse pathogens, including bacteria and DNA/RNA viruses,” said a senior officer of the Ministry of Science and Technology.
Article continues after this advertisementThe study conducted by the scientists has established a reliable strategy for fluorogenic organic molecule-based GQ-RCP platform to diagnose Covid-19 clinical samples and is the first practical demonstration of it, the Ministry said.
RELATED STORIES
Omicron spread prompts push for home testing
Chinese scientists say new highly accurate coronavirus test gives results within minutes
EXPLAINER: What is saliva-based Covid-19 test and where to get it
PRC starts pilot run of cheaper, ‘less invasive’ saliva COVID-19 testing
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.